New trimedat tablet dissolves in mouth – study checks if it works the same
NCT ID NCT07421011
First seen Feb 21, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study compares a new melt-in-mouth version of Trimedat (76.95 mg) to the standard tablet (100 mg) in 36 healthy adults. Researchers want to see if the new form is absorbed similarly and is safe. The goal is to offer a more convenient option for people with digestive issues like IBS or GERD.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Federal Budgetary Institution of Science "North-West Public Health Research Center"
RECRUITINGSaint Petersburg, 191036, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.